Moore’s Sicko stirs controversy

June 13, 2007
Sales and Marketing

Michael Moore's latest film opens at cinemas this month and has predictably raised passions with its critical dissection of the …

Avandia scare casts doubt over its future for Alzheimer’s

June 13, 2007
Sales and Marketing Avandia, diabetes, safety

 New safety warnings about cardiovascular side-effects seen in patients taking Avandia have cast a shadow over the drug’s future as …

ProStrakan begins pan-European launch campaign with Tostran

June 11, 2007
Sales and Marketing

ProStrakan has unveiled Tostran in the UK, the first in a pan-European programme of product launches.Tostran is a testosterone replacement …

Latest news from Datamonitor

June 8, 2007
Research and Development, Sales and Marketing

Accorda enrols first patient in phase III MS studyAcorda Therapeutics has begun a second phase III clinical study of Fampridine-SR …

Scientists hail new gene discovery a landmark

June 7, 2007
Research and Development

DNA samples from 17,000 people across the UK have helped a consortium of scientists to pinpoint genes responsible for diseases …

Quintiles invests

June 7, 2007
Research and Development

Contract research organisation Quintiles is to spend £7.5 million (€11 million) on a new home for its Scottish product development …

Amgen boosts pipeline with spending spree

June 7, 2007
Research and Development, Sales and Marketing

Amgen has spent $720 million acquiring two US biotech companies in deals that add potential treatments for diabetes and kidney …

Sanofi supports Gardasil with disease awareness campaign

June 7, 2007
Medical Communications

Sanofi Pasteur MSD has launched an awareness campaign to encourage women to talk about cervical cancer, the human papillomavirus and …

MHRA investigates links in spate of counterfeits

June 6, 2007
Manufacturing and Production

Counterfeit versions of a prostate cancer drug have prompted the MHRA to issue its third alert about fake drugs in …

BMS launches next generation arthritis treatment Orencia

June 6, 2007
Sales and Marketing

Bristol-Myers Squibb has launched its next generation rheumatoid arthritis treatment Orencia in the UK, offering patients a novel way of …

Bavarian Nordic secures $1.6 billion deal with US government

June 6, 2007
Sales and Marketing

Danish company Bavarian Nordic has secured a massive new contract to provide the US with millions of doses of smallpox …

HCA launches media relations best practice guide

June 5, 2007
Medical Communications

The Healthcare Communications Association has unveiled a new guide to working with the media, the first in a series of …

Product roundup from Datamonitor

June 4, 2007
Sales and Marketing

Celsion completes enrolment in phase I liver cancer studyCelsion has completed its phase I dose escalation study, using ThermoDox, to …

Clew to promote Novartis’ Aclasta

May 31, 2007
Medical Communications

Novartis has appointed Clew Communications to run a pre-launch and launch PR campaign for its new osteoporosis drug.Aclasta (zoledronic acid) …

NICE approves Pfizer’s Champix

May 31, 2007

Pfizer's first-in-class smoking cessation drug Champix has received approval from NICE one month before England's smoking ban comes into effect.Champix …

China’s former medicines regulator sentenced to death

May 31, 2007
Sales and Marketing

The former head of China's medicines regulator has been sentenced to death after being found guilty of taking bribes to …

Genzyme buys cancer specialists Bioenvision

May 31, 2007
Research and Development

Genzyme is to spend $345 million on acquiring specialist pharma company Bioenvision and its oncology portfolio.Genzyme already co-markets with Bioenvision …

Avandia safety concerns hit GSK shares

May 31, 2007
Sales and Marketing

Shares in GSK have taken another hit after news that US prescribers have turned away from diabetes drug Avandia in …

Product roundup from Datamonitor

May 29, 2007
Sales and Marketing

ADHD drug as effective in boys as girls, says ShireUK pharmaceutical company Shire has said that results from a study …

Industry outlines concerns with NICE to Parliament

May 24, 2007

NICE's shortfalls have compromised public confidence in the cost and clinical-effectiveness body, the pharmaceutical industry has told MPs.The comments were …

The Gateway to Local Adoption Series

Latest content